Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical implants; sells medical devices; provides technology services; and engages in research and development activities. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Lim, Yujing

Employees

Website

www.osteopore.com

IPO Date

2019-09-23

Headquarters

2 Tukang Innovation Grove #09-06/07, JTC MedTech Hub, Singapore 6000, Singapore

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.